Chinese regulators have slowed a wave of humanoid robot initial public offerings after Unitree Robotics shares plunged roughly 55% from their peak. The move signals growing scrutiny over whether soaring valuations align with actual commercial demand in the sector.

At least half a dozen companies, including Deep Robotics, X Square Robot, and AGIBOT, are preparing to list. Regulators are employing informal "window guidance" to hold some deals back, with one source describing the process as effectively frozen for now. This intervention follows Unitree's volatile debut in August, where retail investors ordered more than 8,000 times the available shares, briefly pushing the company's valuation to approximately $67 billion on its first trading day.

Regulatory concerns over valuation sustainability

Authorities are questioning the extent of genuine commercial demand. Local governments currently fund 80% to 90% of some robot data centers and joint ventures, a mechanism that helps generate revenue and support IPO valuations. One person close to investors indicated that valuations at some robot companies could fall 60% to 70% if revenue tied to these data-collection centers were removed.

Unitree’s underlying business shows rapid growth, with revenue more than quadrupling to 1.7 billion yuan (approximately $252 million) in 2025. However, its IPO still valued the company at roughly 219 times last year’s earnings. The disparity between high valuations and limited real-world adoption is stark when viewed against broader industry metrics.

Global adoption remains nascent

The International Federation of Robotics reported that only about 7,000 humanoid robots were sold worldwide for industrial and professional uses in 2025. By comparison, manufacturers installed about 542,000 conventional industrial robots in 2024, nearly 80 times the humanoid tally.

Tesla faces similar commercialization hurdles

Tesla Inc. (NASDAQ: TSLA) faces its own test with the Optimus project. CEO Elon Musk confirmed that space in Fremont previously used for Model S and Model X manufacturing will be converted into an Optimus factory. Musk described Optimus as the "hardest product to scale manufacturing" Tesla has ever attempted, warning that the production ramp will initially be "quite flat and long" as the company builds a new supply chain from scratch.

Market sentiment reflects skepticism regarding near-term consumer availability. Polymarket traders place the chance of Tesla making a humanoid robot available for public purchase before December 31 at about 6%. Factory deployments and enterprise pilots do not count toward this metric, meaning significant progress may not trigger a positive market resolution.

What the numbers show

A critical divergence exists between financial performance and market valuation. While Unitree’s revenue grew significantly to 1.7 billion yuan, the company’s IPO valuation of $9 billion implies a multiple of 219 times earnings. When juxtaposed with the global sales volume of just 7,000 humanoid units, this suggests the market is pricing in exponential future adoption rather than current operational scale. Furthermore, the potential 60% to 70% drop in valuations if government-subsidized revenue is excluded highlights a heavy dependency on state-funded infrastructure rather than organic commercial traction.

A Chinese humanoid robot named Tiangong Ultra ran the 100 meters faster than Usain Bolt’s human world record on Saturday at the World Humanoid Robot Games in Beijing. The robot clocked 9.39 seconds in a preliminary heat, edging the 9.58-second mark set by Jamaican sprinter Usain Bolt in 2009.

Honor’s robot, Lightning, finished second at 9.47 seconds, also beating Bolt’s record before collapsing. Tiangong stumbled toward the sidelines and crashed into a padded barrier meant to stop the robots. Lightning fell and had to be carried away on a stretcher.

Endurance and Market Reaction

Lightning also won the Beijing E-Town Humanoid Robot Half-Marathon, finishing in 50 minutes and 26 seconds. Its finish was faster than the men’s human half-marathon world record of 57:20.

Investor appetite for the sector intensified this week when shares of Unitree Robotics, China’s leading humanoid robot maker, rose more than fivefold on their first day of trading in Shanghai. The surge valued the company at nearly $50 billion, according to Reuters.

Strategic Context

In November 2023, China identified humanoid robots as a strategic industry, expecting advances in AI and hardware to boost their use in manufacturing and logistics. The games drew 2,056 robots from 666 teams across 16 countries, up sharply from last year’s 280 teams.

The exhibition follows the U.S. Federal Communications Commission adding foreign-made humanoid robots to its Covered List, barring new imports as it pushes a domestic supply chain.

What the Numbers Show

The participation data reveals a rapid expansion in the global humanoid robotics ecosystem. The number of teams increased from 280 last year to 666 this year, while the total number of robots deployed rose to 2,056. This indicates that not only are more entities entering the space, but each team is deploying significantly more units, suggesting improved manufacturing scalability or testing intensity.